glp-1 agonist therapy consultation preparation Agonists: A Comprehensive Overview How to use GLP-1 receptor
Description
Patients should be advised that they may not have glycemic improvement for 24 weeks after initiating treatment with long-acting GLP-1 receptor agonists

15: 297302 [DOI] [PubMed] [Google Scholar] 140.Usdin TB, Mezey E, Button DC, et al

The therapeutic class is experiencing unprecedented demand as prescriber awareness of pleiotropic benefits, including kidney disease event reduction and major adverse cardiovascular event reduction, reshapes treatment algorithms

Patients are left waiting during this time, unsure when they will receive their medication

This condition occurs when blood flow to the optic nerve becomes restricted, resulting in sudden, painless vision loss that typically affects one eye
The current study cannot fully separate those possibilities
